| P50 | author | Antonella Viola | Q50923744 |
| | Bianca Calì | Q60984758 |
| P2093 | author name string | Barbara Molon | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Posttranscriptional control of T cell effector function by aerobic glycolysis | Q24606942 |
| | Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 |
| | mTOR signaling in growth control and disease | Q24634174 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | Trial watch: IDO inhibitors in cancer therapy | Q27006866 |
| | Glutamine and cancer: cell biology, physiology, and clinical opportunities | Q27011818 |
| | Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide | Q27694770 |
| | Targeting HIF-1 for cancer therapy | Q27860504 |
| | Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 |
| | Metabolic Reprogramming of Immune Cells in Cancer Progression | Q28081682 |
| | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 |
| | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 |
| | Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development | Q28245741 |
| | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 |
| | Regulation of immune responses by L-arginine metabolism | Q29614284 |
| | Autophagy and metabolism | Q29615974 |
| | The LKB1-AMPK pathway: metabolism and growth control in tumour suppression | Q29617506 |
| | AMP-activated protein kinase induces a p53-dependent metabolic checkpoint | Q29618123 |
| | The impact of O2 availability on human cancer | Q29619884 |
| | Tumor metabolism as modulator of immune response and tumor progression | Q33353192 |
| | Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses | Q33423703 |
| | Signaling defects in T lymphocytes of patients with malignancy | Q33740933 |
| | Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. | Q33818673 |
| | The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function | Q33838591 |
| | Anergic T cells are metabolically anergic | Q33908515 |
| | Proteomic method identifies proteins nitrated in vivo during inflammatory challenge | Q33947294 |
| | Cancer-induced defective cytotoxic T lymphocyte effector function: another mechanism how antigenic tumors escape immune-mediated killing | Q34022805 |
| | The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation | Q34242691 |
| | Indoleamine 2,3 dioxygenase and metabolic control of immune responses | Q34308495 |
| | Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells | Q34415738 |
| | mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. | Q34481477 |
| | The CD28 signaling pathway regulates glucose metabolism | Q34525357 |
| | Tryptophan-degrading enzymes in tumoral immune resistance | Q35042385 |
| | Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation. | Q35067933 |
| | HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 |
| | Hypoxia-inducible factors as essential regulators of inflammation | Q35130618 |
| | Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. | Q35237477 |
| | PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation | Q35311785 |
| | T cell metabolic fitness in antitumor immunity | Q35371293 |
| | Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 |
| | Aryl hydrocarbon receptor ligands in cancer: friend and foe. | Q35458027 |
| | Arginases I and II: do their functions overlap? | Q35722017 |
| | Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking | Q35723690 |
| | Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. | Q36054460 |
| | Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer | Q36260673 |
| | Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. | Q36403503 |
| | Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities | Q36601025 |
| | Metabolic regulation of T lymphocytes | Q36711431 |
| | Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival | Q37199519 |
| | Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? | Q37492248 |
| | Prognostic significance of regulatory T cells in tumor | Q37754132 |
| | Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives | Q37954141 |
| | Lactate: a metabolic key player in cancer | Q37956296 |
| | From tumor cell metabolism to tumor immune escape | Q38008488 |
| | Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion | Q38054472 |
| | Metabolism of stromal and immune cells in health and disease | Q38227775 |
| | Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death | Q38901228 |
| | A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells | Q39043650 |
| | Glycolytic metabolism and tumour response to fractionated irradiation. | Q39758697 |
| | Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway | Q39980595 |
| | Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma | Q40041177 |
| | Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients | Q40257073 |
| | The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo | Q41530637 |
| | Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? | Q42858457 |
| | Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy | Q43102151 |
| | Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity | Q43144666 |
| | The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin | Q43199035 |
| | Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses | Q45020410 |
| | Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance | Q47755230 |
| | Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. | Q55474168 |
| | Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer | Q57254166 |
| | High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers | Q73519226 |
| | Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death | Q74638430 |
| | THE VASCULAR SPACE OF GROWING TUMORS | Q77070747 |
| | Inhibitory effect of tumor cell-derived lactic acid on human T cells | Q79666516 |
| | Modulation of human T-cell functions by reactive nitrogen species | Q83823148 |
| | High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients | Q84782027 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | T Cells and Cancer: How Metabolism Shapes Immunity | |
| P478 | volume | 7 | |